vs

Side-by-side financial comparison of AerSale Corp (ASLE) and HARROW, INC. (HROW). Click either name above to swap in a different company.

AerSale Corp is the larger business by last-quarter revenue ($90.9M vs $89.1M, roughly 1.0× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs 5.9%, a 1.5% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs -4.0%). AerSale Corp produced more free cash flow last quarter ($9.8M vs $8.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 0.2%).

AerSale, Inc. is a Doral, Florida-based global supplier of aftermarket commercial jet aircraft, engines, used materials, and aeronautical engineering services to passenger and cargo airlines, government, multinational original equipment manufacturers, and independent MROs. AerSale is a member of the Aircraft Fleet Recycling Association.

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

ASLE vs HROW — Head-to-Head

Bigger by revenue
ASLE
ASLE
1.0× larger
ASLE
$90.9M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+37.3% gap
HROW
33.3%
-4.0%
ASLE
Higher net margin
HROW
HROW
1.5% more per $
HROW
7.4%
5.9%
ASLE
More free cash flow
ASLE
ASLE
$1.7M more FCF
ASLE
$9.8M
$8.1M
HROW
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
0.2%
ASLE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASLE
ASLE
HROW
HROW
Revenue
$90.9M
$89.1M
Net Profit
$5.4M
$6.6M
Gross Margin
34.1%
79.3%
Operating Margin
7.8%
17.5%
Net Margin
5.9%
7.4%
Revenue YoY
-4.0%
33.3%
Net Profit YoY
99.7%
-2.2%
EPS (diluted)
$0.10
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASLE
ASLE
HROW
HROW
Q4 25
$90.9M
$89.1M
Q3 25
$71.2M
$71.6M
Q2 25
$107.4M
$63.7M
Q1 25
$65.8M
$47.8M
Q4 24
$94.7M
$66.8M
Q3 24
$82.7M
$49.3M
Q2 24
$77.1M
$48.9M
Q1 24
$90.5M
$34.6M
Net Profit
ASLE
ASLE
HROW
HROW
Q4 25
$5.4M
$6.6M
Q3 25
$-120.0K
$1.0M
Q2 25
$8.6M
$5.0M
Q1 25
$-5.3M
$-17.8M
Q4 24
$2.7M
$6.8M
Q3 24
$509.0K
$-4.2M
Q2 24
$-3.6M
$-6.5M
Q1 24
$6.3M
$-13.6M
Gross Margin
ASLE
ASLE
HROW
HROW
Q4 25
34.1%
79.3%
Q3 25
30.2%
75.3%
Q2 25
32.9%
74.5%
Q1 25
27.3%
67.5%
Q4 24
31.4%
78.8%
Q3 24
28.6%
75.6%
Q2 24
28.2%
74.4%
Q1 24
31.8%
69.5%
Operating Margin
ASLE
ASLE
HROW
HROW
Q4 25
7.8%
17.5%
Q3 25
4.0%
20.6%
Q2 25
11.7%
17.9%
Q1 25
-10.1%
-23.5%
Q4 24
5.2%
19.3%
Q3 24
2.4%
2.7%
Q2 24
-2.4%
3.1%
Q1 24
5.2%
-20.0%
Net Margin
ASLE
ASLE
HROW
HROW
Q4 25
5.9%
7.4%
Q3 25
-0.2%
1.4%
Q2 25
8.0%
7.8%
Q1 25
-8.0%
-37.2%
Q4 24
2.9%
10.1%
Q3 24
0.6%
-8.6%
Q2 24
-4.7%
-13.2%
Q1 24
6.9%
-39.2%
EPS (diluted)
ASLE
ASLE
HROW
HROW
Q4 25
$0.10
$0.20
Q3 25
$0.00
$0.03
Q2 25
$0.18
$0.13
Q1 25
$-0.10
$-0.50
Q4 24
$0.05
$0.19
Q3 24
$0.01
$-0.12
Q2 24
$-0.07
$-0.18
Q1 24
$0.12
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASLE
ASLE
HROW
HROW
Cash + ST InvestmentsLiquidity on hand
$4.4M
$72.9M
Total DebtLower is stronger
$1.3M
$250.0M
Stockholders' EquityBook value
$424.4M
$52.4M
Total Assets
$640.5M
$399.5M
Debt / EquityLower = less leverage
0.00×
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASLE
ASLE
HROW
HROW
Q4 25
$4.4M
$72.9M
Q3 25
$5.3M
$74.3M
Q2 25
$5.7M
$53.0M
Q1 25
$4.7M
$66.7M
Q4 24
$4.7M
$47.2M
Q3 24
$9.8M
$72.6M
Q2 24
$4.3M
$71.0M
Q1 24
$2.6M
$76.0M
Total Debt
ASLE
ASLE
HROW
HROW
Q4 25
$1.3M
$250.0M
Q3 25
$1.5M
$347.2M
Q2 25
$907.0K
$250.6M
Q1 25
$1.1M
$256.9M
Q4 24
$1.2M
$262.7M
Q3 24
$376.0K
$230.7M
Q2 24
$522.0K
$236.3M
Q1 24
$3.5M
$243.4M
Stockholders' Equity
ASLE
ASLE
HROW
HROW
Q4 25
$424.4M
$52.4M
Q3 25
$417.1M
$47.0M
Q2 25
$415.9M
$49.7M
Q1 25
$406.5M
$56.5M
Q4 24
$455.6M
$69.7M
Q3 24
$451.5M
$58.0M
Q2 24
$449.8M
$58.5M
Q1 24
$452.0M
$60.6M
Total Assets
ASLE
ASLE
HROW
HROW
Q4 25
$640.5M
$399.5M
Q3 25
$646.3M
$363.1M
Q2 25
$646.7M
$345.0M
Q1 25
$646.1M
$364.2M
Q4 24
$604.7M
$389.0M
Q3 24
$601.5M
$351.5M
Q2 24
$598.7M
$306.6M
Q1 24
$571.7M
$295.5M
Debt / Equity
ASLE
ASLE
HROW
HROW
Q4 25
0.00×
4.77×
Q3 25
0.00×
7.39×
Q2 25
0.00×
5.05×
Q1 25
0.00×
4.55×
Q4 24
0.00×
3.77×
Q3 24
0.00×
3.98×
Q2 24
0.00×
4.04×
Q1 24
0.01×
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASLE
ASLE
HROW
HROW
Operating Cash FlowLast quarter
$11.4M
$8.4M
Free Cash FlowOCF − Capex
$9.8M
$8.1M
FCF MarginFCF / Revenue
10.8%
9.1%
Capex IntensityCapex / Revenue
1.7%
0.4%
Cash ConversionOCF / Net Profit
2.11×
1.27×
TTM Free Cash FlowTrailing 4 quarters
$-29.1M
$43.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASLE
ASLE
HROW
HROW
Q4 25
$11.4M
$8.4M
Q3 25
$-8.9M
$16.6M
Q2 25
$19.8M
$-803.0K
Q1 25
$-45.2M
$19.7M
Q4 24
$37.5M
$-17.8M
Q3 24
$10.4M
$3.0M
Q2 24
$-15.3M
$-2.7M
Q1 24
$-21.5M
$-4.6M
Free Cash Flow
ASLE
ASLE
HROW
HROW
Q4 25
$9.8M
$8.1M
Q3 25
$-9.8M
$16.4M
Q2 25
$18.6M
$-969.0K
Q1 25
$-47.6M
$19.5M
Q4 24
$32.3M
$-18.3M
Q3 24
$8.9M
$2.3M
Q2 24
$-18.9M
$-3.1M
Q1 24
$-25.0M
$-4.7M
FCF Margin
ASLE
ASLE
HROW
HROW
Q4 25
10.8%
9.1%
Q3 25
-13.8%
22.9%
Q2 25
17.3%
-1.5%
Q1 25
-72.4%
40.8%
Q4 24
34.0%
-27.4%
Q3 24
10.7%
4.8%
Q2 24
-24.6%
-6.3%
Q1 24
-27.7%
-13.6%
Capex Intensity
ASLE
ASLE
HROW
HROW
Q4 25
1.7%
0.4%
Q3 25
1.3%
0.3%
Q2 25
1.1%
0.3%
Q1 25
3.7%
0.4%
Q4 24
5.6%
0.8%
Q3 24
1.9%
1.2%
Q2 24
4.7%
0.7%
Q1 24
3.9%
0.3%
Cash Conversion
ASLE
ASLE
HROW
HROW
Q4 25
2.11×
1.27×
Q3 25
16.26×
Q2 25
2.31×
-0.16×
Q1 25
Q4 24
13.89×
-2.62×
Q3 24
20.52×
Q2 24
Q1 24
-3.42×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASLE
ASLE

Products$57.8M64%
Maintenance$23.2M26%
Leasing Arrangements$9.9M11%

HROW
HROW

Segment breakdown not available.

Related Comparisons